Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride in combination with at least one glucocorticoid corticosteroid for use in the treatment of muscular dystrophy

RS68069B1Active Publication Date: 2026-05-29ITALFARMACO SPA

View PDF 0 Cites 0 Cited by

Patent Information

Patent Timeline

03 Feb 2012

Application

29 May 2026

Publication

RS68069B1

IPC: A61K31/167; A61K9/00; A61K9/10; A61K9/14; A61K9/16; A61K9/20; A61K9/48; A61K31/325; A61K31/573; A61K31/58; A61K45/06; A61P21/00; A61P21/04; A61P29/00; A61P43/00

CPC: A61K31/167; A61K31/573; A61K31/58; A61K2300/00; A61K9/0095; A61K45/06; A61K31/27; A61K31/325

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗

Check patentability, review prior art and ask IP Agent with full patent context.

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.